Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation

Bone Marrow Transplantation

Volumn 18, Issue 6, 1996, Pages 1029-1034

  Van Gelder, M ^a,b   Van Bekkum, D W ^a  

^a CRUCELL HOLLAND BV   (Netherlands)

^b St Clara Hospital   (Netherlands)

Author keywords

Autoimmune disease; Autoimmune encephalomyelitis; Autologous bone marrow transplantation; Conditioning; T cell depletion

Indexed keywords

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; FEMALE; LYMPHOCYTE; MALE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RELAPSE;

ANIMALS; AUTOIMMUNE DISEASES; BONE MARROW TRANSPLANTATION; CYCLOPHOSPHAMIDE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; LYMPHOCYTE DEPLETION; RADIATION CHIMERA; RATS; RATS, INBRED BUF; RECURRENCE; REMISSION INDUCTION; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 0030462050     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Raine CS. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest 1984; 50: 608-635.
2. Pender MP. Demyelination and neurological signs in experimental allergic encephalomyelitis. J Neuroimmunol 1987; 15: 11-24.
3. Pettinelli CB, McFarlin DE. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lytl+2-T lymphocytes. J Immunol 1981; 127: 1420-1423.
4. Katz D, Taubenberger JK, Canella B et al. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993; 34: 661-669.
5. Pender MP, Stanley GP, Yoong, G, Nguyen KB. The neuropathology of chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rat by inoculation with whole spinal cord and treatment with cyclosporin A. Acta Neuropathol 1990; 80: 172-183.
6. Van Gelder M, Kinwel-Bohré EPM, Van Bekkum DW. Treatment of expeimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT. Bone Marrow Transplant 1993; 11:233-241.
7. Van Gelder M, Van Bekkum DW. Treatment of relapsing experimental autoimmune encephalomyelitis in rats with allogeneic bone marrow transplantation from a resistant strain. Bone Marrow Transplant 1995; 16: 343-351.
8. Fassas A, Anagnostopoulos A, Kazis A et al. Peripheral blood progenitor transplantation for treatment of multiple sclerosis. Bone Marrow Transplant 1996; 17 (Suppl. 1): S6.
9. Tienari PJ, Salonen O, Wilkström J et al. Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings. J Neurol Neurosurg Psych 1992; 55: 883-886.
10. Drobyski WR, Ash RC, Casper JT et al. Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. Blood 1994; 83: 1980-1987.
11. Van Bekkum DW, Bohré EPM, Houben PFJ, Knaan-Shanzer S. Regression of adjuvant-induced arthritis in rats following bone marrow transplantation. Proc Natl Acad Sci USA 1989; 86: 10090-10094.
12. Pestronk A, Drachman DB, Teoh R, Adams RN. Combined short-term immunotherapy for experimental autoimmune myasthenia gravis. Ann Neurol 1983; 14: 235-241.
13. Karussis DM, Slavin S, Ben-Nun A. Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation. J Neuro-immunol 1992; 39: 201-210.
14. Theobald M, Hoffmann T, Bunjes D, Heit W. Comparative analysis of in vitro T cell depletion with radiotherapy, combination chemotherapy, and the monoclonal antibody CAM-PATH-1G, using limiting dilution methodology. Transplantation 1990; 49: 553-559.
15. Moreau T, Thorpe J, Miller D et al. Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis. Lancet 1994; 344: 298-301.
16. Mendez MF, Pogacar S. Malignant monophasic multiple sclerosis or 'Marburg's disease'. Neurology 1988; 38: 1153-1155.
17. Dippel DWJ, Visser LH, Buljevac D et al. Bone marrow transplantation for progressive multiple sclerosis. Will the (potential) benefit be worth the risk? Brain (submitted).